During the past decade, Dokters van Nederhoven conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dokters van Nederhoven" are "Coronary Heart Disease (CHD)" (1 trials), "Dyslipidemias" (1 trials), "High Cholesterol" (1 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Dokters van Nederhoven" in a lesser frequency.

Most popular intervention types in "Dokters van Nederhoven" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Evolocumab" (1 trials), "Ezetimibe 10mg" (1 trials) and "Obicetrapib 5mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dokters van Nederhoven" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dokters van Nederhoven". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Dokters van Nederhoven, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dokters van Nederhoven, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".